Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Aditya Kohli Biography and Net Worth

COO & Director of HilleVax

Aditya Kohli, Ph.D., is Chief Operating Officer at HilleVax. Aditya is a Venture Partner with Frazier Healthcare Partners, where he focuses on company creation. In addition to HilleVax, he has co-founded Scout Bio, Passage Bio (NASDAQ: PASG) and Phathom Pharmaceuticals (NASDAQ: PHAT). He is the former Chief Business Officer at Phathom and serves on the board of Scout Bio. Prior to Frazier, Aditya was a management consultant with McKinsey & Company, where he led engagements advising global biopharmaceutical companies on business development, research and development, and marketing and sales strategy. Aditya received his Ph.D. from the UC Berkeley and UC San Francisco joint graduate program in bioengineering and holds B.S. and M.Eng. degrees in biological engineering from MIT.

How old is Aditya Kohli?: Mr. Kohli is currently 35 years old. There are 5 older executives and no younger executives at HilleVax. The oldest executive at HilleVax is Dr. Robert M. Hershberg M.D., Ph.D., President, CEO & Chairman of the Board, who is 62 years old. Learn More on Aditya Kohli's age.
How do I contact Aditya Kohli?: The corporate mailing address for Mr. Kohli and other HilleVax executives is , , . HilleVax can also be reached via phone at 617-213-5054 and via email at [email protected]. Learn More on Aditya Kohli's contact information.
Has Aditya Kohli been buying or selling shares of HilleVax?: Aditya Kohli has not been actively trading shares of HilleVax over the course of the past ninety days. Learn More on Aditya Kohli's trading history.
Who are HilleVax's active insiders?: HilleVax's insider roster includes Robert Hershberg (CEO, President & Chair), Aditya Kohli (COO & Director ), and David Socks (CFO & Chief Bus. Officer ). Learn More on HilleVax's active insiders.
Are insiders buying or selling shares of HilleVax?: During the last twelve months, HilleVax insiders bought shares 2 times. They purchased a total of 10,100 shares worth more than $149,550.00. During the last twelve months, insiders at the sold shares 17 times. They sold a total of 123,039 shares worth more than $987,111,242.27. The most recent insider tranaction occured on April, 5th when Director Aditya Kohli sold 6,000 shares worth more than $86,640.00. Insiders at HilleVax own 29.3% of the company. Learn More about insider trades at HilleVax.
Information on this page was last updated on 4/5/2024.

Aditya Kohli Insider Trading History at HilleVax

Aditya Kohli Buying and Selling Activity at HilleVax

HilleVax Company Overview

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $12.79

$11.99

$13.20

50 Day Range

MA: $15.79

$11.86

$19.75

2 Week Range

Now: $12.79

$9.94

$20.22

Volume

369,590 shs

Average Volume

156,447 shs

Market Capitalization

$635.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65